Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for fibroblast-targeted antirestenotic therapies; extends experimental mechanisms of arterial repair but leaves clinical translation open.
Shi et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: